342 related articles for article (PubMed ID: 29726987)
1. Admission macrophage migration inhibitory factor predicts long-term prognosis in patients with ST-elevation myocardial infarction.
Deng XN; Wang XY; Yu HY; Chen SM; Xu XY; Huai W; Liu GH; Ma QB; Zhang YY; Dart AM; Du XJ; Gao W
Eur Heart J Qual Care Clin Outcomes; 2018 Jul; 4(3):208-219. PubMed ID: 29726987
[TBL] [Abstract][Full Text] [Related]
2. Circulating MIF Levels Predict Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction After Percutaneous Coronary Intervention.
Zhao Q; Men L; Li XM; Liu F; Shan CF; Zhou XR; Song N; Zhu JJ; Gao XL; Ma YT; Du XJ; Gao XM; Yang YN
Can J Cardiol; 2019 Oct; 35(10):1366-1376. PubMed ID: 31495686
[TBL] [Abstract][Full Text] [Related]
3. Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes.
Yu H; Wang X; Deng X; Zhang Y; Gao W
Mediators Inflamm; 2019; 2019():8276180. PubMed ID: 30983881
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarction.
Deng F; Zhao Q; Deng Y; Wu Y; Zhou D; Liu W; Yuan Z; Zhou J
Medicine (Baltimore); 2018 Oct; 97(43):e12991. PubMed ID: 30412132
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kacprzak M; Zielinska M
Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Pusuroglu H; Cakmak HA; Akgul O; Erturk M; Surgit O; Akkaya E; Bulut U; Yildirim A
Rev Port Cardiol; 2015 Oct; 34(10):597-606. PubMed ID: 26387826
[TBL] [Abstract][Full Text] [Related]
7. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.
Saito D; Nakanishi R; Watanabe I; Yabe T; Okubo R; Amano H; Toda M; Ikeda T
Heart Vessels; 2018 May; 33(5):453-461. PubMed ID: 29143103
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
10. Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Zhu Y; Hu C; Du Y; Zhang J; Liu J; Han H; Zhao Y
BMC Cardiovasc Disord; 2019 May; 19(1):107. PubMed ID: 31077149
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.
Coelho-Lima J; Georgiopoulos G; Ahmed J; Adil SER; Gaskin D; Bakogiannis C; Sopova K; Ahmed F; Ahmed H; Spray L; Richardson G; Bagnall AJ; Stellos K; Stamatelopoulos K; Spyridopoulos I
Heart; 2021 Dec; 107(23):1881-1888. PubMed ID: 34544804
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.
Tian C; Song J; He D; Wu J; Sun Z; Sun Z
Int Heart J; 2018 Mar; 59(2):286-292. PubMed ID: 29563382
[TBL] [Abstract][Full Text] [Related]
13. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.
Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A
Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563
[TBL] [Abstract][Full Text] [Related]
15. The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: A four-year prospective study.
Isik T; Kurt M; Tanboga IH; Ayhan E; Gunaydin ZY; Kaya A; Uyarel H
Cardiol J; 2016; 23(3):281-8. PubMed ID: 26711461
[TBL] [Abstract][Full Text] [Related]
16. Time-Dependent Change in Omentin-1 Level Correlated with Early Improvement of Myocardial Function in Patients with First Anterior ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.
Zhu Y; Hu C; Du Y; Zhang J; Liu J; Cheng G; Han H; Zhao Y
J Atheroscler Thromb; 2019 Oct; 26(10):856-867. PubMed ID: 30853697
[TBL] [Abstract][Full Text] [Related]
17. Direct Admission Versus Interhospital Transfer for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Kawecki D; Gierlotka M; Morawiec B; Hawranek M; Tajstra M; Skrzypek M; Wojakowski W; Poloński L; Nowalany-Kozielska E; Gąsior M
JACC Cardiovasc Interv; 2017 Mar; 10(5):438-447. PubMed ID: 28216215
[TBL] [Abstract][Full Text] [Related]
18. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
He PC; Duan CY; Liu YH; Wei XB; Lin SG
BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
[TBL] [Abstract][Full Text] [Related]
20. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC
PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
